Literature DB >> 30303767

Prevention of Cell Growth by Suppression of Villin Expression in Lithocholic Acid-Stimulated HepG2 Cells.

Munetaka Ozeki1, Wulamujiang Aini2,3, Aya Miyagawa-Hayashino2,4, Keiji Tamaki1.   

Abstract

Cholestasis is a condition wherein bile flow is interrupted and lithocholic acid is known to play a key role in causing severe liver injury. In this study, we performed in-depth analysis of the morphological changes in bile canaliculi and the biological role of villin in cholestasis using lithocholic acid-stimulated HepG2 human hepatocarcinoma cells. We confirmed disruption of the bile canaliculi in liver sections from a liver allograft patient with cholestasis. Lithocholic acid caused strong cytotoxicity in HepG2 cells, which was associated with abnormal morphology. Lithocholic acid reduced villin expression, which recovered in the presence of nuclear receptor agonists. Furthermore, villin mRNA expression increased following small interfering RNA (siRNA)-mediated knockdown of the nuclear farnesoid X receptor and pregnane X receptor. Villin knockdown using siRNA caused cell growth arrest in HepG2 cells. The effect of villin-knockdown on whole-genome expression in HepG2 cells was analyzed by DNA microarray. Our data suggest that lithocholic acid caused cell growth arrest by suppressing villin expression via farnesoid X receptor and pregnane X receptor in HepG2 cells.

Entities:  

Keywords:  actin-binding protein; bile acid; cytotoxicity; hepatocyte; liver transplantation

Mesh:

Substances:

Year:  2018        PMID: 30303767      PMCID: PMC6354318          DOI: 10.1369/0022155418804507

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  34 in total

1.  FBXO31 is down-regulated and may function as a tumor suppressor in hepatocellular carcinoma.

Authors:  Hai-Li Huang; Wen-Ling Zheng; Rui Zhao; Bao Zhang; Wen-Li Ma
Journal:  Oncol Rep       Date:  2010-09       Impact factor: 3.906

Review 2.  Actin cytoskeleton dynamics and the cell division cycle.

Authors:  Yi-Wen Heng; Cheng-Gee Koh
Journal:  Int J Biochem Cell Biol       Date:  2010-04-20       Impact factor: 5.085

Review 3.  Biliary atresia and other cholestatic childhood diseases: Advances and future challenges.

Authors:  Henkjan J Verkade; Jorge A Bezerra; Mark Davenport; Richard A Schreiber; Georgina Mieli-Vergani; Jan B Hulscher; Ronald J Sokol; Deirdre A Kelly; Benno Ure; Peter F Whitington; Marianne Samyn; Claus Petersen
Journal:  J Hepatol       Date:  2016-05-06       Impact factor: 25.083

Review 4.  Bile salt biotransformations by human intestinal bacteria.

Authors:  Jason M Ridlon; Dae-Joong Kang; Phillip B Hylemon
Journal:  J Lipid Res       Date:  2005-11-18       Impact factor: 5.922

Review 5.  New insights into autoimmune cholangitis through animal models.

Authors:  Michael Trauner; Peter Fickert; Anna Baghdasaryan; Thierry Claudel; Emina Halilbasic; Tarek Moustafa; Martin Wagner; Gernot Zollner
Journal:  Dig Dis       Date:  2010-05-07       Impact factor: 2.404

Review 6.  Pathogenesis of cholestatic liver disease and therapeutic approaches.

Authors:  Gideon M Hirschfield; E Jenny Heathcote; M Eric Gershwin
Journal:  Gastroenterology       Date:  2010-09-16       Impact factor: 22.682

7.  Oncostatin M-stimulated apical plasma membrane biogenesis requires p27(Kip1)-regulated cell cycle dynamics.

Authors:  Sven C D Van IJzendoorn; Delphine Théard; Johanna M Van Der Wouden; Willy Visser; Kacper A Wojtal; Dick Hoekstra
Journal:  Mol Biol Cell       Date:  2004-07-07       Impact factor: 4.138

8.  Actin and myosin deposition around bile canaliculi: a predictor of clinical outcome in biliary atresia.

Authors:  O Segawa; T Miyano; T Fujimoto; S Watanabe; M Hirose; T Fujiwara
Journal:  J Pediatr Surg       Date:  1993-06       Impact factor: 2.545

9.  Bile canalicular abnormalities in the early phase of a mouse model of sclerosing cholangitis.

Authors:  Masashi Miyao; Munetaka Ozeki; Hitoshi Abiru; Sho Manabe; Hirokazu Kotani; Tatsuaki Tsuruyama; Keiji Tamaki
Journal:  Dig Liver Dis       Date:  2012-10-27       Impact factor: 4.088

10.  A G protein-coupled receptor responsive to bile acids.

Authors:  Yuji Kawamata; Ryo Fujii; Masaki Hosoya; Masataka Harada; Hiromi Yoshida; Masanori Miwa; Shoji Fukusumi; Yugo Habata; Takashi Itoh; Yasushi Shintani; Shuji Hinuma; Yukio Fujisawa; Masahiko Fujino
Journal:  J Biol Chem       Date:  2003-01-10       Impact factor: 5.157

View more
  2 in total

1.  Association between Immunohistochemistry Markers and Tumor Features and Their Diagnostic and Prognostic Values in Intrahepatic Cholangiocarcinoma.

Authors:  Jiannan He; Cao Zhang; Qinye Shi; Fangping Bao; Xiang Pan; Yue Kuai; Jingjin Wu; Li Li; Ping Chen; Yian Huang; Jianhong Xu
Journal:  Comput Math Methods Med       Date:  2022-04-28       Impact factor: 2.809

Review 2.  Cytoskeletal Remodeling in Cancer.

Authors:  Jaya Aseervatham
Journal:  Biology (Basel)       Date:  2020-11-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.